Dual Anticancer Drug-Loaded Self-Assembled Nanomaterials Delivery System for the Treatment of Prostate Cancer

In both PC3pip and LNCAP prostate cancer cells, crizotinib and marizomib nanomaterials demonstrated noticeable cytotoxic effects in a dose-responsive method.